rasagiline has been researched along with Central Nervous System Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, CL; Mátyus, P | 1 |
1 other study(ies) available for rasagiline and Central Nervous System Diseases
| Article | Year |
|---|---|
Metabolism-Activated Multitargeting (MAMUT): An Innovative Multitargeting Approach to Drug Design and Development.
Topics: Amine Oxidase (Copper-Containing); Anti-Inflammatory Agents; Antipsychotic Agents; Cell Adhesion Molecules; Central Nervous System Diseases; Clozapine; Drug Design; Drug Synergism; Humans; Indans; Ligands; Monoamine Oxidase; Pharmaceutical Preparations; Receptor, Muscarinic M1 | 2016 |